Evidence map›Paper›PMID 38494584›Full record

ArticleInternational urology and nephrology2024

Can urinary caspase-3 and cytochrome c levels be used as predictive biomarkers in the management of unilateral antenatal hydronephrosis?

Seyide Görkem Zeybek, İsmail Selvi, Tayfun Oktar, M İrfan Dönmez, Orhan Ziylan, Şule Seçkin, Canan Küçükgergin

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Seyide Görkem ZeybekDepartment of Biochemistry, Institute of Health Sciences, Istanbul University, Istanbul, Turkey.
İsmail SelviDepartment of Urology, Division of Pediatric Urology, Istanbul Faculty of Medicine, Istanbul University, Çapa-Fatih, 34093, Istanbul, Turkey. ismselvi33@hotmail.com.ORCID http://orcid.org/0000-0003-3578-0732
Tayfun OktarDepartment of Urology, Division of Pediatric Urology, Istanbul Faculty of Medicine, Istanbul University, Çapa-Fatih, 34093, Istanbul, Turkey.
M İrfan DönmezDepartment of Urology, Division of Pediatric Urology, Istanbul Faculty of Medicine, Istanbul University, Çapa-Fatih, 34093, Istanbul, Turkey.
Orhan ZiylanDepartment of Urology, Division of Pediatric Urology, Istanbul Faculty of Medicine, Istanbul University, Çapa-Fatih, 34093, Istanbul, Turkey.
Şule SeçkinDepartment of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Canan KüçükgerginDepartment of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Istanbul University · TR

Funding

Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi TYL-2021-37576
6 · The paper itself

Abstract

purposeWe aimed to investigate the urinary caspase-3 and cytochrome c levels in patients with unilateral antenatal hydronephrosis and to determine whether changes in urinary biomarker levels could be useful for both predicting the need for surgical intervention due to ureteropelvic junction obstruction (UPJO) and postoperative surgical success.

methodsSixty-five children with a history of unilateral antenatal hydronephrosis and postnatal anteroposterior diameter ≥ 10 mm were included in this prospective case-control study between January 2013 and December 2021. The obstruction group consisted of 33 patients (28 boys, 84.8%) who underwent open dismembered pyeloplasty due to UPJO. The non-obstructive dilatation (NOD) group consisted of 32 patients (27 boys, 84.4%) with stable or improving hydronephrosis and no significant reduction in ipsilateral split renal function during follow-up, whereas 34 healthy children were enrolled in the study as a control group. Urinary urinary caspase-3 and cytochrome c levels using ELISA were measured.

resultsThe median preoperative urinary caspase-3 level was significantly higher in the obstruction group when compared to the NOD group (4.82 ng/mgCr vs. 2.61 ng/mgCr, p = 0.013) as well as the control group (4.82 ng/mgCr vs. 1.72 ng/mgCr, p = 0.002). In the postoperative period, urinary caspase-3 levels significantly decreased compared to preoperative measurements (4.82 ng/mgCr vs. 2.51 ng/mgCr, p = 0.006) and became similar to the control group (2.51 ng/mgCr vs. 1.72 ng/mgCr, p = 0.422). On the other hand, no significant differences were observed in urinary cytochrome c levels between the groups. All patients who underwent pyeloplasty achieved postoperative resolution in hydronephrosis and improved drainage on MAG-3, so none of the patients required re-do pyeloplasty. Postoperative decrease in caspase-3 level was found to be compatible with adequate urine drainage on MAG-3 scan. The cut-off value of urinary caspase-3 to predict patients requiring pyeloplasty was found to be 3.31 ng/mg creatinine with 63.6% sensitivity, 62.5% specificity (AUC = 0.679). In the multivariable analysis, urinary caspase-3 level (OR: 1.653, p = 0.019), anteroposterior pelvic diameter (OR: 1.401, p = 0.001), and split renal function on MAG-3 (OR: 1.277, p = 0.011) were found to be independent factors in determining patients who require surgery.

conclusionBased on our preliminary findings, urinary caspase-3 levels could be a useful biomarker not only for predicting the need for surgical intervention but also for determining the postoperative surgical success in children with UPJO.

Indexed as

BiomarkersCaspase 3Cytochromes cHydronephrosisUreteral ObstructionCase-Control StudiesChild, PreschoolFemaleHumansInfantMalePredictive Value of TestsProspective StudiesBiomarkersCaspase 3Cytochromes cAntenatal hydronephrosisCaspase-3Cytochrome cPyeloplastyUreteropelvic junction obstruction

Identifiers

PMID38494584
OpenAlexW4392924069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.